Zhaoping Qiu

1.1k total citations
17 papers, 759 citations indexed

About

Zhaoping Qiu is a scholar working on Molecular Biology, Cancer Research and Biochemistry. According to data from OpenAlex, Zhaoping Qiu has authored 17 papers receiving a total of 759 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 8 papers in Cancer Research and 5 papers in Biochemistry. Recurrent topics in Zhaoping Qiu's work include RNA modifications and cancer (6 papers), Eicosanoids and Hypertension Pharmacology (5 papers) and Nitric Oxide and Endothelin Effects (4 papers). Zhaoping Qiu is often cited by papers focused on RNA modifications and cancer (6 papers), Eicosanoids and Hypertension Pharmacology (5 papers) and Nitric Oxide and Endothelin Effects (4 papers). Zhaoping Qiu collaborates with scholars based in China, United States and Germany. Zhaoping Qiu's co-authors include Xianghuo He, Weijie Guo, Shenglin Huang, Qifeng Wang, Yingjun Zhao, Ming Yao, Zhiao Chen, Daling Zhu, Taoyang Chen and Jianren Gu and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Gastroenterology and PLoS ONE.

In The Last Decade

Zhaoping Qiu

17 papers receiving 754 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zhaoping Qiu China 14 555 455 149 64 52 17 759
Noga Gadir United States 10 696 1.3× 186 0.4× 110 0.7× 99 1.5× 86 1.7× 18 871
Ganeshkumar Rajendran United States 12 445 0.8× 227 0.5× 106 0.7× 91 1.4× 46 0.9× 21 689
Takafumi Mayama Japan 8 468 0.8× 466 1.0× 68 0.5× 173 2.7× 30 0.6× 10 755
Bert Cruys Belgium 8 324 0.6× 230 0.5× 37 0.2× 58 0.9× 59 1.1× 10 533
Avi Kumar United States 6 328 0.6× 169 0.4× 85 0.6× 80 1.3× 33 0.6× 12 489
Kateřina Rohlenová Czechia 9 383 0.7× 236 0.5× 56 0.4× 65 1.0× 94 1.8× 18 618
Chunping Qiu China 19 432 0.8× 282 0.6× 83 0.6× 119 1.9× 31 0.6× 31 741
Jee‐Youn Kim South Korea 13 472 0.9× 236 0.5× 52 0.3× 130 2.0× 49 0.9× 28 696
Jianan Yang China 13 277 0.5× 172 0.4× 78 0.5× 82 1.3× 67 1.3× 16 465

Countries citing papers authored by Zhaoping Qiu

Since Specialization
Citations

This map shows the geographic impact of Zhaoping Qiu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhaoping Qiu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhaoping Qiu more than expected).

Fields of papers citing papers by Zhaoping Qiu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhaoping Qiu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhaoping Qiu. The network helps show where Zhaoping Qiu may publish in the future.

Co-authorship network of co-authors of Zhaoping Qiu

This figure shows the co-authorship network connecting the top 25 collaborators of Zhaoping Qiu. A scholar is included among the top collaborators of Zhaoping Qiu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhaoping Qiu. Zhaoping Qiu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Qiu, Zhaoping, Weijie Guo, Bo Dong, et al.. (2022). EBF1 promotes triple-negative breast cancer progression by surveillance of the HIF1α pathway. Proceedings of the National Academy of Sciences. 119(28). e2119518119–e2119518119. 18 indexed citations
2.
Qiu, Zhaoping, Bo Dong, Weijie Guo, et al.. (2021). STK39 promotes breast cancer invasion and metastasis by increasing SNAI1 activity upon phosphorylation. Theranostics. 11(16). 7658–7670. 14 indexed citations
3.
Dong, Bo, Zhaoping Qiu, & Yadi Wu. (2020). Tackle Epithelial-Mesenchymal Transition With Epigenetic Drugs in Cancer. Frontiers in Pharmacology. 11. 596239–596239. 25 indexed citations
4.
Wang, Jianlin, Qian Yu, Zhaoping Qiu, et al.. (2020). The combined effect of epigenetic inhibitors for LSD1 and BRD4 alters prostate cancer growth and invasion. Aging. 12(1). 397–415. 14 indexed citations
5.
Wang, Jianlin, Zhaoping Qiu, & Yadi Wu. (2018). Ubiquitin Regulation: The Histone Modifying Enzyme′s Story. Cells. 7(9). 118–118. 25 indexed citations
6.
Qiu, Zhaoping, Weijie Guo, Qifeng Wang, et al.. (2015). MicroRNA-124 Reduces the Pentose Phosphate Pathway and Proliferation by Targeting PRPS1 and RPIA mRNAs in Human Colorectal Cancer Cells. Gastroenterology. 149(6). 1587–1598.e11. 77 indexed citations
7.
Chen, Di, Weijie Guo, Zhaoping Qiu, et al.. (2015). MicroRNA-30d-5p inhibits tumour cell proliferation and motility by directly targeting CCNE2 in non-small cell lung cancer. Cancer Letters. 362(2). 208–217. 100 indexed citations
8.
Guo, Weijie, Zhaoping Qiu, Zhichao Wang, et al.. (2015). MiR‐199a‐5p is negatively associated with malignancies and regulates glycolysis and lactate production by targeting hexokinase 2 in liver cancer. Hepatology. 62(4). 1132–1144. 194 indexed citations
9.
Zha, Ruopeng, Weijie Guo, Zhenfeng Zhang, et al.. (2014). Genome-Wide Screening Identified That miR-134 Acts as a Metastasis Suppressor by Targeting Integrin β1 in Hepatocellular Carcinoma. PLoS ONE. 9(2). e87665–e87665. 62 indexed citations
10.
Zhang, Yuannv, Zhaoping Qiu, Lin Wei, et al.. (2014). Integrated Analysis of Mutation Data from Various Sources Identifies Key Genes and Signaling Pathways in Hepatocellular Carcinoma. PLoS ONE. 9(7). e100854–e100854. 33 indexed citations
11.
Nie, Xiaowei, Shuai Shi, Jun Ma, et al.. (2013). Heme oxygenase-1 induces 15-lipoxygenase expression during hypoxia-induced pulmonary hypertension. The International Journal of Biochemistry & Cell Biology. 45(5). 964–972. 7 indexed citations
12.
Yu, Lei, et al.. (2012). Cellular mechanisms and intracellular signaling pathways for the modulation of eNOS in pulmonary arteries by 15-HETE. Journal of Receptors and Signal Transduction. 32(2). 87–95. 7 indexed citations
13.
Qiu, Zhaoping, Xiufeng Yu, Xu Gao, et al.. (2012). The MicroRNA-328 Regulates Hypoxic Pulmonary Hypertension by Targeting at Insulin Growth Factor 1 Receptor and L-Type Calcium Channel-α1C. Hypertension. 59(5). 1006–1013. 112 indexed citations
14.
Nie, Xiaowei, Shasha Song, Lei Zhang, et al.. (2011). 15-Hydroxyeicosatetraenoic acid (15-HETE) protects pulmonary artery smooth muscle cells from apoptosis via inducible nitric oxide synthase (iNOS) pathway. Prostaglandins & Other Lipid Mediators. 97(1-2). 50–59. 15 indexed citations
15.
Qiu, Zhaoping, et al.. (2010). Hypoxia suppresses Kv 2.1 channel expression through endogenous 15-hydroxyeicosatetraenoic acid in rat pulmonary artery. The Journal of Physiological Sciences. 60(5). 373–381. 8 indexed citations
16.
Wang, Shuang, Yali Wang, Jing Jiang, et al.. (2010). 15-HETE protects rat pulmonary arterial smooth muscle cells from apoptosis via the PI3K/Akt pathway. Prostaglandins & Other Lipid Mediators. 91(1-2). 51–60. 33 indexed citations
17.
Guo, Lei, Xiaobo Tang, Lihua Sun, et al.. (2009). Role of protein kinase C in 15-HETE-induced hypoxic pulmonary vasoconstriction. Prostaglandins Leukotrienes and Essential Fatty Acids. 80(2-3). 115–123. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Noga Gadir Breakdown of academic impact, for papers by Ganeshkumar Rajendran Breakdown of academic impact, for papers by Takafumi Mayama Breakdown of academic impact, for papers by Bert Cruys Breakdown of academic impact, for papers by Avi Kumar Breakdown of academic impact, for papers by Kateřina Rohlenová Breakdown of academic impact, for papers by Chunping Qiu Breakdown of academic impact, for papers by Jee‐Youn Kim Breakdown of academic impact, for papers by Jianan Yang
Rankless by CCL
2026